|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.370 USD | 0.00% |
|
-0.42% | +31.67% |
| May. 13 | Protalix BioTherapeutics, Inc., Q1 2026 Earnings Call, May 13, 2026 | |
| May. 13 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | -0.42% | +5.80% | +8.72% | +31.67% | +52.90% | +47.20% | +50.96% | -62.99% | 191M | |
| +0.86% | +1.43% | +7.05% | +35.30% | +11.29% | +48.50% | +160.39% | +389.88% | +1,365.90% | 1,057B | |
| +1.59% | +4.09% | +9.29% | +15.78% | +27.28% | +55.34% | +53.96% | +53.33% | +110.67% | 624B | |
| +0.95% | +1.91% | +10.42% | +30.52% | +13.51% | +35.91% | +81.14% | +119.44% | +306.46% | 454B | |
| +1.60% | +6.25% | +6.96% | +10.28% | +8.20% | +33.95% | +29.84% | +2.25% | +42.15% | 341B | |
| -0.60% | +1.52% | +2.06% | +11.61% | +15.78% | +35.68% | +39.76% | +50.05% | +54.10% | 297B | |
| -0.14% | +0.60% | -8.91% | -9.21% | -8.12% | +16.17% | +17.53% | +49.41% | +174.69% | 262B | |
| +0.09% | -2.82% | +2.90% | +23.33% | -1.43% | -28.29% | -41.71% | +12.31% | +70.99% | 215B | |
| +1.22% | +2.66% | +7.00% | +9.14% | +14.89% | +21.87% | +59.73% | +51.80% | +126.98% | 201B | |
| -1.18% | -3.70% | +3.32% | -0.84% | +5.35% | +14.23% | +66.51% | +87.35% | +49.40% | 162B | |
| -0.16% | -2.04% | +2.08% | -9.11% | -1.45% | -3.20% | -34.58% | -41.12% | -33.21% | 143B | |
| +0.94% | +2.22% | +12.89% | +5.76% | +15.11% | +26.87% | -4.08% | -9.15% | -17.96% | 126B | |
| +0.90% | -1.71% | +0.45% | +10.94% | +5.29% | +1.08% | +33.70% | +138.08% | +408.42% | 120B | |
| -0.43% | -1.69% | +3.37% | -5.06% | -8.09% | -10.78% | -22.55% | -13.67% | -0.74% | 104B | |
| +0.73% | +0.16% | -1.56% | -4.98% | +5.21% | +38.04% | +37.52% | +8.45% | -7.47% | 101B | |
| +2.83% | +1.24% | -1.12% | -16.16% | -10.03% | +2.46% | +82.26% | +79.69% | +470.46% | 72.43B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| +2.60% | +3.07% | +10.66% | +5.87% | +16.81% | +29.84% | +28.10% | +52.24% | +26.69% | 53.64B | |
| -2.66% | +0.49% | +6.37% | -4.64% | -10.27% | -7.04% | +13.03% | -13.08% | +242.08% | 53.47B | |
| -0.30% | -4.95% | +16.34% | +19.64% | +24.45% | +58.15% | -10.55% | -10.04% | -49.97% | 51.61B | |
| Average | +0.38% | +0.32% | +5.02% | +7.20% | +8.18% | +22.19% | +33.54% | +55.69% | +172.46% | 225.13B | |
| Weighted average by Cap. | +0.53% | +1.41% | +5.64% | +16.20% | +10.57% | +31.39% | +64.92% | +128.85% | +420.08% |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
